Quantitative Fundus Autofluorescence in Retinal Disorders

视网膜疾病中的定量眼底自发荧光

• 批准号: 8619402
• 负责人: Janet Ruthe Sparrow
• 金额: $ 46.97万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-06-01 至 2018-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8619402
• 关键词: Abbreviations; Address; Affect; Age; Age related macular degeneration; Alleles; Biological; Carrier State; Cells; Chemicals; Choroidal Neovascularization; Clinical; Complement Factor H; Complex; Complex Mixtures; Confidence Intervals; Data; Deposition; Diagnosis; Disease; Disease Progression; Electroretinography; Epithelial; Ethnic Origin; Etiology; Exhibits; Eye; Flecks; Fundus; Gender; Genetic; Genotype; Gray unit of radiation dose; Image; Individual; Influentials; Investigation; Lasers; Legal Blindness; Light; Link; Lipofuscin; Longitudinal Studies; Measurement; Measures; Membrane; Methods; Monitor; Mutation; Normal Range; Nuclear; Omi serine protease; Ophthalmoscopy; Optical Coherence Tomography; Optics; Outcome; Participant; Pathogenesis; Patients; Pattern; Phagocytosis; Phenotype; Photoreceptors; Physics; Pigments; Positioning Attribute; Predisposition; Process; Research Personnel; Retina; Retinal; Retinal Degeneration; Retinal Diseases; Retinal Pigments; Retinaldehyde; Retinitis; Retinitis Pigmentosa; Scanning; Single Nucleotide Polymorphism; Sparrows; Stargardt' s disease; Structure of retinal pigment epithelium; Susceptibility Gene; Testing; Therapeutic; Variant; Work; aged; base; clinical phenotype; cohort; early onset; fluorophore; follow-up; geographic atrophy; human disease; macular dystrophy; pattern dystrophies; peripherin; public health relevance; risk variant

DESCRIPTION (provided by applicant): The inherent autofluorescence (AF) of the fundus originates from RPE lipofuscin. While RPE lipofuscin is amassed even in healthy eyes, homozygous mutations in ABCA4 are well known to confer accelerated formation of these fluorophores. Moreover, imaging of fundus AF by confocal scanning laser ophthalmoscopy (cSLO) has shown that the patterns and intensities of AF deviate from normal in several retinal disorders. Thus we aim to demonstrate that a standardized approach to quantifying fundus AF (qAF) can assist in the diagnosis of retinal disease, in the monitoring of disease progression and in the assessment of therapeutic outcomes. To enable this investigation we have gathered normative qAF data from a large number of participants with healthy eye status (aged 6-60) so as to establish ranges of qAF values with respect to age, gender and ethnicity. Going forward we will use these normal values to examine for genotype/phenotype correlations between specific ABCA4 alleles and fundus AF levels (qAF) in patients diagnosed with ABCA4- associated disease (Aim 1.1). In longitudinal studies we will measure changes in qAF values after 1 and 2 year follow-up of ABCA4-affected individuals (Aim 1.2). We will determine whether the carrier state (heterozygous) of ABCA4 is associated with elevated RPE lipofuscin, the latter being measured as qAF and compared to age-matched normals (Aim 1.3). We will also investigate the cellular basis of retinal flecks (Aim 1.4). In Aim 2, we will determine whether the quantification of fundus SW-AF can aid in differentiating between pattern dystrophy (PD) associated with PRPH2/RDS mutations versus similar phenotypes observed with ABCA4 variants (Aim 2.1). We will also compare qAF values in individuals presenting with bull's eye macular dystrophy that is of ABCA4- versus non-ABCA4 origin (Aim 2.2). In patients with RP, we will measure qAF over the autofluorescent rings that are often a feature of this disorder. qAF Intensities inside, within and outside the rings will be compared to levels in our normal controls so as to further the use of fundus AF imaging to monitor disease progression in RP. In Aim 4, we will determine whether elevated fundus AF is a factor influencing the onset and progression of AMD when controlling for specific CFH and ARMS2 alleles. In summary, the studies proposed in this application will examine the contribution that the lipofuscin of retina makes to the onset and progression of several retinal diseases and will demonstrate that quantitation of fundus AF facilitates the diagnosis and monitoring of some retinal disorders.

描述（由申请人提供）：眼底的固有自发荧光（AF）源自RPE脂褐素。虽然RPE脂褐素即使在健康的眼睛中也会积累，但众所周知ABCA 4中的纯合突变会加速这些荧光团的形成。此外，通过共焦扫描激光检眼镜（cSLO）对眼底AF的成像显示，在几种视网膜疾病中，AF的模式和强度偏离正常。因此，我们的目的是证明，一个标准化的方法来量化眼底AF（qAF）可以帮助诊断视网膜疾病，监测疾病进展和评估治疗结果。为了进行这项研究，我们从大量眼睛健康的参与者（6-60岁）中收集了规范性qAF数据，以确定与年龄、性别和种族有关的qAF值范围。今后，我们将使用这些正常值来检查诊断为ABCA 4相关疾病的患者中特定ABCA 4等位基因与眼底AF水平（qAF）之间的基因型/表型相关性（目标1.1）。在纵向研究中，我们将测量ABCA 4受影响个体随访1年和2年后qAF值的变化（目标1.2）。我们将确定ABCA 4的携带状态（杂合）是否与RPE脂褐素升高相关，后者被测量为qAF并与年龄匹配的正常人进行比较（目标1.3）。我们还将研究视网膜颤动的细胞基础（目标1.4）。在目标2中，我们将确定 眼底SW-AF的定量可以帮助区分与PRPH 2/RDS突变相关的模式营养不良（PD）与用ABCA 4变体观察到的类似表型（Aim 2.1）。我们还将比较ABCA 4与非ABCA 4起源的牛眼黄斑营养不良个体的qAF值（Aim 2.2）。在RP患者中，我们将在自体荧光环上测量qAF，这通常是这种疾病的一个特征。qAF环内、环内和环外的强度将与我们的正常对照中的水平进行比较，以便进一步使用眼底AF成像来监测RP中的疾病进展。在目标4中，我们将确定当控制特定CFH和ARMS 2等位基因时，眼底AF升高是否是影响AMD发作和进展的因素。总之，本申请中提出的研究将检查视网膜的脂褐质对几种视网膜疾病的发作和进展的贡献，并将证明眼底AF的定量有助于一些视网膜疾病的诊断和监测。